Early-stage analytical development strategies for cell therapy

Cell & Gene Therapy Insights 2024; 10(11), 1493–1503

DOI: 10.18609/cgti.2024.171

Published: 16 January
Expert Roundtable
Ramon Mendoza, Kyle Carter, Seth Peterson



In this expert roundtable, three highly experienced industry professionals discuss the importance and nuances of phase-appropriate analytical control in early-stage cell therapy development. The panelists share insights on key areas of innovation such as automated solutions, digital PCR, and next-generation sequencing, and share their advice on early engagement with regulatory agencies to help ensure successful outcomes in getting cell therapies to patients.